treatments [2:200,000/mm 3 for 2 consecutive weeks. 1 Do not administer if platelet count is >400,000/mm 3 ; assess the platelet count weekly and resume romiplostim at a dosage reduced by 1 mcg/kg weekly once the platelet count is] FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Drug Status Rx Availability Prescription only C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Drug Class Platelet-stimulating agents Related Drugs Idiopathic Thrombocytopenic Purpura prednisone , triamcinolone , dexamethasone , Decadron , Deltasone , cortisone , Promacta , Kenalog-40 , Gammagard , RhoGAM , Gamunex , Privigen , Sterapred , eltrombopag , Nplate , Octagam , Dexasone , Gamunex-C , Intron A , MICRhoGAM , Carimune , Dexpak Taperpak , Flebogamma , Prednicot , More... Romiplostim Rating 2 User Reviews 8.7 /10 2 User Reviews 8.7 Rate it! which isn't
detrimental Romiplostim massacre
EmoticonEmoticon